PICKERING GRANT, CEO, reported an open-market or private sale at Vaxcyte, Inc. involving 587.000000 shares for an estimated $37763.47. Reported holdings after the transaction were 151286.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chief Executive Officer
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.
The price reported is a weighted-average price. The shares were sold at prices ranging from $62.01 to $62.96. The reporting person will provide upon request to the SEC, the issuer or security holder o…
Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
The price reported is a weighted-average price. The shares were sold at prices ranging from $63.01 to $64.00. The reporting person will provide upon request to the SEC, the issuer or security holder o…
The price reported is a weighted-average price. The shares were sold at prices ranging from $64.13 to $64.60. The reporting person will provide upon request to the SEC, the issuer or security holder o…
The price reported is a weighted-average price. The shares were sold at prices ranging from $62.01 to $62.94. The reporting person will provide upon request to the SEC, the issuer or security holder o…
Shares are held directly by a trust for the benefit of the Reporting Person's son.
The price reported is a weighted-average price. The shares were sold at prices ranging from $63.13 to $64.00. The reporting person will provide upon request to the SEC, the issuer or security holder o…
0 other filings
0 recent txs